Case Study · Sleep

Case L.: Sleep onset latency dropped from 90+ minutes to under 20; night wakings from 3–4 to 0–1.

7 years old · Autism, chronic insomnia, melatonin non-responder

Benefits verified prior to treatment

BCBS·Aetna·Cigna·UnitedHealthcare FDA-cleared TMS

Insurance Accepted

BCBS·Aetna·Cigna·UHC

Google Rating

4.9 / 5.0

Highly Rated by Families in Illinois

Physician Reviewed

Every Treatment Plan

Overseen by a licensed physician

FDA-Cleared TMS

Non-Invasive Therapy

For depression, anxiety, OCD

Presenting concerns

  • Sleep onset latency averaging 90+ minutes.
  • Multiple night wakings disrupting the whole household.
  • Daytime irritability and reduced learning capacity.

qEEG findings

Elevated beta at sleep-onset eyes-closed condition; reduced sleep-spindle precursors.

Treatment plan & timeline

Protocol: qEEG-guided TMS plus a structured sleep-hygiene protocol with parent coaching.

Wk 0

Baseline

qEEG, 2-week actigraphy + parent sleep diary.

Wk 3

First gains

Sleep onset latency to ~40 min, night wakings to 2.

Wk 6

Consolidation

Sleep onset latency to ~20 min, often 0 night wakings.

Wk 10

Repeat qEEG

Beta at eyes-closed normalized. Family discontinued melatonin.

Progress tracking — outcome metrics

MeasureBaselineFollow-upChange
Sleep onset latency (min)9217−82%
Night wakings / night3.40.6−82%
Parent-rated morning mood (1–10)3.58.2+4.7

Parent observations

  • “He falls asleep on his own now — that has never been possible.”
  • “He wakes up calm instead of frantic.”

Outcome summary

Sleep architecture normalized, melatonin discontinued, and daytime regulation improved as a downstream effect of restored sleep.

Related services

Begin your child's case with a consultation.

Verify your insurance benefits or request a consultation — most families hear back within one business day.